| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/08/2001 | WO2001016312A2 Nucleic acid based modulators of gene expression |
| 03/08/2001 | WO2001016308A2 Plant sterol acyltransferases |
| 03/08/2001 | WO2001016307A2 Plant promoter sequences from maize for selective control of gene expression |
| 03/08/2001 | WO2001016306A2 Chimeric antisense oligonucleotides and cell transfecting formulations thereof |
| 03/08/2001 | WO2001016305A2 Nucleotide sequences encoding an insectidal protein complex from serratia |
| 03/08/2001 | WO2001016304A2 Genetically engineered cell lines, and their uses, in particular for neurotoxicity testing |
| 03/08/2001 | WO2001016303A2 Nucleic acids which code for the enzyme activities of the spinosyn biosynthesis |
| 03/08/2001 | WO2001016300A2 Method of identifying inhibitors of cdc25 |
| 03/08/2001 | WO2001016298A1 Cloning of mouse gpr10 receptor |
| 03/08/2001 | WO2001016297A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | WO2001016293A2 Dna encoding the human serine protease t |
| 03/08/2001 | WO2001016292A2 37 staphylococcus aureus genes and polypeptides |
| 03/08/2001 | WO2001016290A2 Dna encoding the human serine protease eos |
| 03/08/2001 | WO2001016289A2 Zymogen activation system |
| 03/08/2001 | WO2001016288A2 Dna encoding the human serine protease c-e |
| 03/08/2001 | WO2001016287A2 Exogenic allelism |
| 03/08/2001 | WO2001016179A1 Novel g protein-coupled receptor protein and dna thereof |
| 03/08/2001 | WO2001016178A1 MATERIALS AND METHODS FOR INHIBITION OF IgE PRODUCTION |
| 03/08/2001 | WO2001016177A1 Mouse g-protein coupled 7 transmembrane receptor, canoman |
| 03/08/2001 | WO2001016176A2 Transgenic animal model for neurodegenerative diseases |
| 03/08/2001 | WO2001016175A1 A novel human rab gene and its coding polypeptide |
| 03/08/2001 | WO2001016174A2 Induction of cytotoxic t lymphocyte response by hla class ia restricted epitopes of mycobacterial heat shock protein 65 |
| 03/08/2001 | WO2001016172A1 Vaccine antigens of moraxella |
| 03/08/2001 | WO2001016171A1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
| 03/08/2001 | WO2001016170A2 Card proteins involved in cell death regulation |
| 03/08/2001 | WO2001016165A2 Apoptin-associating protein |
| 03/08/2001 | WO2001016156A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/08/2001 | WO2001016155A1 Antibodies specific for fullerenes |
| 03/08/2001 | WO2001016150A2 Nucleoside analogues |
| 03/08/2001 | WO2001016149A2 2-azapurine compounds and their use |
| 03/08/2001 | WO2001016144A2 Plant derived calcium-dependent calmodulin-binding polypeptides and polynucleotides encoding same |
| 03/08/2001 | WO2001015800A1 Method and device for performing operations at charged microlocations |
| 03/08/2001 | WO2001015755A2 Methods and compositions for delivery of pharmaceutical agents |
| 03/08/2001 | WO2001015741A2 Genetic suppressor elements against human immunodeficiency virus |
| 03/08/2001 | WO2001015740A1 Single-stranded oligodeoxynucleotide mutational vectors |
| 03/08/2001 | WO2001015739A1 Antisense modulation of human rho family gene expression |
| 03/08/2001 | WO2001015736A2 Interferon-beta conjugates |
| 03/08/2001 | WO2001015704A1 Medicaments that contain xenogenic oligo- or/and polyribonucleotides |
| 03/08/2001 | WO2001015676A2 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 03/08/2001 | WO2001015521A1 Transgenic mammal capable of facilitating production of donor-specific functional immunity |
| 03/08/2001 | WO2001015520A1 Pa28 modified transgenic mice |
| 03/08/2001 | WO2001015511A2 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses |
| 03/08/2001 | WO2001001143A3 Attachment of biomolecule to a polymeric solid support by cycloaddition of a linker |
| 03/08/2001 | WO2001000848A8 Useful polypeptide |
| 03/08/2001 | WO2001000840A9 Insecticidal and nematicidal proteins |
| 03/08/2001 | WO2000077184A9 Caspase-8 crystals, models and methods |
| 03/08/2001 | WO2000073501A3 Nucleic acid molecules with specific identification of native prpsc, their production and the use thereof |
| 03/08/2001 | WO2000068396A3 Bacillus circulans xylanase mutants |
| 03/08/2001 | WO2000068395A3 Sulfohydrolases, corresponding amino acid and nucleotide sequences, sulfohydrolase preparations, processes, and products thereof |
| 03/08/2001 | WO2000066735A3 Human ion channel proteins |
| 03/08/2001 | WO2000063425A3 Compound assay using nematodes |
| 03/08/2001 | WO2000061766A3 Telomerase-specific cancer vaccine |
| 03/08/2001 | WO2000061634A3 Ecotin-variant modulators of serine proteases |
| 03/08/2001 | WO2000061624A8 48 human secreted proteins |
| 03/08/2001 | WO2000058475A3 Streptococcus pneumoniae antigens |
| 03/08/2001 | WO2000049137A3 Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell |
| 03/08/2001 | WO2000047755A3 Plant udp-glucose epimerases |
| 03/08/2001 | WO2000047726A3 Plant polyphenol oxidase homologs |
| 03/08/2001 | WO2000044902A3 Biomarkers and assays for carcinogenesis induced by phenobarbitol |
| 03/08/2001 | WO2000039283A8 Use of cd40 engagement to alter t cell receptor usage |
| 03/08/2001 | WO2000026246A9 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |
| 03/08/2001 | WO2000023588A8 G-protein coupled receptors |
| 03/08/2001 | WO2000022150A9 Limonene and other metabolites of geranyl pyrophosphate for insect control |
| 03/08/2001 | WO2000020447A8 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
| 03/08/2001 | WO2000018961A3 Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 03/08/2001 | WO2000017655A8 Water-soluble fluorescent semiconductor nanocrystals |
| 03/08/2001 | WO2000012736A9 A new method of identifying non-host plant disease resistance genes |
| 03/08/2001 | WO1999058663A9 METHODS AND COMPOSITIONS FOR SCREENING FOR MODULATORS OF IgE SYNTHESIS, SECRETION AND SWITCH REARRANGEMENT |
| 03/08/2001 | WO1999020723A8 Multiply-substituted protease variant and amylase variant-containing cleaning compositions |
| 03/08/2001 | DE19957268A1 Nucleinsäuren, die für Enzymaktivitäten der Spinosyn-Biosynthese kodieren Nucleic acids which encode enzyme activities of spinosyn biosynthesis |
| 03/08/2001 | DE19942175A1 Methode zum Auffinden von Inhibitoren der Riboflavinbiosynthese Method for finding inhibitors of riboflavin |
| 03/08/2001 | DE19941609A1 Fettsäure-Desaturase-Gen aus Pflanzen Fatty acid desaturase gene from plants |
| 03/08/2001 | DE19941606A1 Verfahren zum Ermitteln von Nuklein- und/oder Aminosäuresequenzen A method for detecting nucleic acids and / or amino acid sequences |
| 03/08/2001 | DE19941478A1 Neue für das thrE-Gen codierende Nukleotidsequenzen und Verfahren zur fermentativen Herstellung von L-Threonin mit coryneformen Bakterien New coding for the thrE gene nucleotide sequences and processes for the fermentative preparation of L-threonine with coryneform bacteria |
| 03/08/2001 | DE19940012A1 Eukaryotic expression plasmid useful for treating peripheral arterial occlusive disease, comprises two expression cassettes, one containing the gene for human vascular endothelial growth factor VEGF165 |
| 03/08/2001 | DE19938390A1 Neue Sequenzvarianten des menschlichen ßl-Adrenozeptorgens und ihre Verwendung New sequence variants of the human ßl-Adrenozeptorgens and their use |
| 03/08/2001 | DE19931819A1 11-Arachidonat-Lipoxygenase-Mutante Arachidonate 11-lipoxygenase mutant |
| 03/08/2001 | CA2645727A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2533856A1 Exogenic allelism |
| 03/08/2001 | CA2481788A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2481756A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2481691A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2481685A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2403243A1 Nucleic acid based modulators of gene expression |
| 03/08/2001 | CA2392010A1 Use of lentiviral vectors for antigen presentation in dendritic cells |
| 03/08/2001 | CA2391868A1 Novel g protein-coupled receptor protein and dna thereof |
| 03/08/2001 | CA2388734A1 37 staphylococcus aureus genes and polypeptides |
| 03/08/2001 | CA2387291A1 Dna encoding the human serine protease t |
| 03/08/2001 | CA2385156A1 In vitro transcription systems and uses |
| 03/08/2001 | CA2384055A1 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | CA2384026A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | CA2383928A1 Chromosome-wide analysis of protein-dna interactions |
| 03/08/2001 | CA2383907A1 Human hydrolytic enzymes |
| 03/08/2001 | CA2383877A1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
| 03/08/2001 | CA2383784A1 Apoptin-associating protein |
| 03/08/2001 | CA2383693A1 Card proteins involved in cell death regulation |
| 03/08/2001 | CA2383606A1 Iren protein, its preparation and use |
| 03/08/2001 | CA2383603A1 Method of identifying inhibitors of cdc25 |
| 03/08/2001 | CA2383601A1 Dna encoding the human serine protease eos |
| 03/08/2001 | CA2383564A1 Transgenic animal model for neurodegenerative diseases |